GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Selling, General, & Admin. Expense

Hard to Treat Diseases (Hard to Treat Diseases) Selling, General, & Admin. Expense : $ Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Hard to Treat Diseases's selling, general, & admin. expense for the three months ended in . 20 was $0.00 Mil. Hard to Treat Diseases does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in . 20.


Hard to Treat Diseases Selling, General, & Admin. Expense Historical Data

The historical data trend for Hard to Treat Diseases's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Selling, General, & Admin. Expense Chart

Hard to Treat Diseases Annual Data
Trend
Selling, General, & Admin. Expense

Hard to Treat Diseases Quarterly Data
Selling, General, & Admin. Expense

Competitive Comparison of Hard to Treat Diseases's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Hard to Treat Diseases's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hard to Treat Diseases's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Selling, General, & Admin. Expense falls into.



Hard to Treat Diseases Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.


Hard to Treat Diseases  (OTCPK:HTDS) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Hard to Treat Diseases Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Traded in Other Exchanges
N/A
Address
2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762
Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines